title: Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis.
authors: Division of Infectious Diseases, Department of Medicine, SUNY Downstate Medical Center, New York, NY, USA.
authors: Brandon
authors: B
authors: Eilertson
authors: Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, USA.
authors: Fernanda
authors: F
authors: Maruri
authors: Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, USA.
authors: Amondrea
authors: A
authors: Blackman
authors: Vanderbilt Technologies for Advanced Genomics, Vanderbilt University, Nashville, TN, USA. Brandon.Eilertson@Downstate.edu.
authors: Miguel
authors: M
authors: Herrera
authors: Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, USA.
authors: Timothy R
authors: TR
authors: Sterling
mesh_terms: D000368:Aged; D000995:Antitubercular Agents / Q000494:pharmacology*; D027081:DNA Gyrase / Q000235:genetics; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones; D027081:DNA Gyrase